Wellcome responds to WHO Global tuberculosis report 2026
The WHO has published its annual Global TB Report, showing that in 2025, an estimated 10.6 million people developed TB and 1.13 million died. Wellcome responds to the findings that, while TB incidence and mortality declined, progress remained behind targets of the WHO End TB Strategy.
2-minute read
2-minute read
Charlie Weller, Head of Vaccines at Wellcome, said:
"We are in the midst of a really exciting moment in TB innovation – improved treatments are working their way to late-stage trials, and a number of vaccines are being tested. It’s promising to see progress being made in tackling the global TB burden, especially increased country investment in the TB response. But there is still work to do - more financing is needed to drive towards global targets.
"As we wait for the results of these trials, we must address the challenge of ensuring equitable access to any TB interventions in countries with the greatest need. From understanding demand across high-burden countries to putting financing mechanisms in place, efforts need to start now to avoid missing opportunities to save lives."
Tags
